{"name":"Ursapharm Arzneimittel GmbH","slug":"ursapharm-arzneimittel-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Posiformin 2 %, bibrocathol","genericName":"Posiformin 2 %, bibrocathol","slug":"posiformin-2-bibrocathol","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Posiformin 2 %, bibrocathol","genericName":"Posiformin 2 %, bibrocathol","slug":"posiformin-2-bibrocathol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNMFdFdWRLTjl2aFIzVXVHc3ZEX2tvb1k0UVd3V0dOYmhWamVxYW1obmZSUER3NXk0QkY0OHY2VUNycld1S2xNTDU4UVdaclJTcEhfT0tlQ29VaElKTVJENEh5Mkw3QXpKZzY4TFVEa0xxS2g3SkJlZTVrVlBUUGk0Xw?oc=5","date":"2026-02-03","type":"pipeline","source":"European table tennis union","summary":"HYLO® named title sponsor of ETTU Champions League Men - European table tennis union","headline":"HYLO® named title sponsor of ETTU Champions League Men","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE94SjZrMVdyazM2dml5TmF6ZE0xLVNWWmZpVDBvVEpoOVdIOEVsSWxzV01oZmpwZDZvd0NNN0Q4TFlYNXBLLVFlcWRFaWl0Y1ZqeHN0Y25XTWs4SnBieGdUOWlXa1dsOGJ4TUgyblNuSQ?oc=5","date":"2025-09-07","type":"trial","source":"ScienceDaily","summary":"Common allergy spray slashes COVID-19 risk in surprising trial - ScienceDaily","headline":"Common allergy spray slashes COVID-19 risk in surprising trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1qUzlaQldKZENMT2o3eUhLbXFtdlFaT2tuenlCbXI3dm92c0JYNWEwWFdrUVd1a3Q3b19RdTRRWThlZWN0SXhSb2hYZDZRYVVoaVU2UXB2RnUxQ2xz?oc=5","date":"2025-09-02","type":"trial","source":"EurekAlert!","summary":"Clinical study shows that nasal spray containing azelastine reduces risk of coronavirus infection by two-thirds - EurekAlert!","headline":"Clinical study shows that nasal spray containing azelastine reduces risk of coronavirus infection by two-thirds - EurekA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOeUVLLUQ4Mm5mR0l3cS1pbHZxVS10bHV2UUhjdEtEM0FNaUZhaDhHWjdaTDR6ZE11eEtpT0FrUmE1ZVFRSXlzN2xXQlVRMjN1TzNEZllXOWc3djljTTVZMmdTSmcwV3lCWFZRX1hmRkdMQ2FNb0dieE8tNlNZeUR5MzVsV1RNdFRReXNRUHA5dTV6Rm1EbjlyZ2ppUEFvb0NrbWlROEdaVTdOT3lZWHNReXc3NWc3WTRKMTY1eWtqd0FPcDdOTDlV?oc=5","date":"2024-07-05","type":"regulatory","source":"Citeline News & Insights","summary":"Pharma Looks To America First: US FDA Holds Overwhelming Lead Over EMA In Novel Approvals - Citeline News & Insights","headline":"Pharma Looks To America First: US FDA Holds Overwhelming Lead Over EMA In Novel Approvals - Citeline News & Insights","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBmYndXelV2eTRMOHVEUmpKYWxMa0tHdUhXU1YxWGV0MEJoWVV6MzRJNmR4RW9JWUhpeVNDM0picXExV0xfOXpjMkM2UTZSUmQtMmUwTl9mMDhKX2cwa3JZ?oc=5","date":"2023-04-26","type":"pipeline","source":"nature.com","summary":"Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients | Scientific Reports - nature.com","headline":"Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients | Scientific Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE0yLTFDVVFSUlVILWpFZjlpT3VReklDS3pxRjZDeFRnSk1CbnoxM2dnZXhpOWVXZkdPWG9La1ZkWkRlRkdBb0pwUVIzWkhhWllVbjNBTURFaHhZcTNMeVV4bE1sWDBJZEl1OTJ5SVQxWQ?oc=5","date":"2022-08-16","type":"pipeline","source":"Straits Research","summary":"OTC Artificial Tears Market Size, Top Trends, Report to 2033 - Straits Research","headline":"OTC Artificial Tears Market Size, Top Trends, Report to 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFA5RUZjUWFYNmE5NGRGWmNGaVVZQnkxdDl4NGE5Tk9BWmZTam5NaVRVc0YxYnBHZXp6U2gtb0F0Ym5xbTk5Z0E4MHFsSHhkczN6bTVFdA?oc=5","date":"2019-06-17","type":"pipeline","source":"Market.us","summary":"Bromelain Market Size, Share, Growth | CAGR of 6.3% - Market.us","headline":"Bromelain Market Size, Share, Growth | CAGR of 6.3%","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}